Stock DNA
Pharmaceuticals & Biotechnology
JPY 19,321 Million (Small Cap)
6.00
NA
0.00%
0.32
9.57%
0.62
Revenue and Profits:
Net Sales:
90,519 Million
(Quarterly Results - Jun 2025)
Net Profit:
584 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.35%
0%
0.35%
6 Months
33.43%
0%
33.43%
1 Year
79.42%
0%
79.42%
2 Years
28.25%
0%
28.25%
3 Years
86.24%
0%
86.24%
4 Years
98.74%
0%
98.74%
5 Years
4.33%
0%
4.33%
Ohki Health Care Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.74%
EBIT Growth (5y)
4.32%
EBIT to Interest (avg)
50.18
Debt to EBITDA (avg)
2.42
Net Debt to Equity (avg)
0.36
Sales to Capital Employed (avg)
9.10
Tax Ratio
31.00%
Dividend Payout Ratio
13.44%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.83%
ROE (avg)
8.59%
Valuation key factors
Factor
Value
P/E Ratio
6
Industry P/E
Price to Book Value
0.50
EV to EBIT
9.65
EV to EBITDA
8.47
EV to Capital Employed
0.63
EV to Sales
0.08
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
6.55%
ROE (Latest)
8.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
Jun'25
Jun'24
Change(%)
Net Sales
90,519.00
87,068.00
3.96%
Operating Profit (PBDIT) excl Other Income
672.00
381.00
76.38%
Interest
34.00
10.00
240.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
584.00
393.00
48.60%
Operating Profit Margin (Excl OI)
6.40%
3.30%
0.31%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2025 is 3.96% vs 6.94% in Jun 2024
Consolidated Net Profit
YoY Growth in quarter ended Jun 2025 is 48.60% vs -25.29% in Jun 2024
Annual Results Snapshot (Consolidated) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
349,452.00
334,661.00
4.42%
Operating Profit (PBDIT) excl Other Income
3,156.00
2,421.00
30.36%
Interest
71.00
35.00
102.86%
Exceptional Items
-175.00
205.00
-185.37%
Consolidate Net Profit
2,643.00
2,126.00
24.32%
Operating Profit Margin (Excl OI)
7.90%
6.10%
0.18%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2025 is 4.42% vs 9.92% in Mar 2024
Consolidated Net Profit
YoY Growth in year ended Mar 2025 is 24.32% vs -2.61% in Mar 2024
About Ohki Health Care Holdings, Inc. 
Ohki Health Care Holdings, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






